Behrad Derakhshan serves as Executive at Edgewise Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Behrad Derakhshan has executed 14 insider transactions totaling $1.5M, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 12, 2025 involved exercising options for 5,781 shares valued at $0.
Behrad Derakhshan currently holds 26,136 shares of Edgewise Therapeutics, Inc. (EWTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Behrad Derakhshan has been a net seller of EWTX stock. They have purchased $0 and sold $1.5M worth of shares.
Behrad Derakhshan's most recent insider trade was on Aug 12, 2025, when they sold 5,781 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $13.39 |
| Discretionary |
| Sep 20, 2024 | EWTX | $1.2M | Sale | 42,068 | $29.03 | Discretionary |
| Sep 20, 2024 | EWTX | $81.2K | Option Exercise | 42,068 | $1.93 | Discretionary |
| May 2, 2024 | EWTX | $32.5K | Sale | 1,718 | $18.91 | Discretionary |
| May 1, 2024 | EWTX | $0 | Option Exercise | 5,208 | $N/A | Discretionary |
| Feb 9, 2024 | EWTX | $96.2K | Sale | 4,800 | $20.04 | Planned |
| Feb 9, 2024 | EWTX | $9.3K | Option Exercise | 4,800 | $1.93 | Planned |
| Feb 8, 2024 | EWTX | $8.9K | Option Exercise | 4,600 | $1.93 | Planned |
| Feb 8, 2024 | EWTX | $92.0K | Sale | 4,600 | $20.01 | Planned |
| Feb 7, 2024 | EWTX | $1.2K | Option Exercise | 600 | $1.93 | Planned |
| Feb 7, 2024 | EWTX | $12.0K | Sale | 600 | $20.00 | Planned |
| May 2, 2023 | EWTX | $15.5K | Sale | 1,747 | $8.90 | Discretionary |
| May 1, 2023 | EWTX | $0 | Option Exercise | 5,208 | $N/A | Discretionary |